One Source Medical Supplies

Important Update for Healthcare Professionals and Patients

The American Diabetes Association has published updated clinical practice recommendations in the Standards of Care in Diabetes-2025. These evidence-based guidelines represent the latest advances in diabetes prevention, diagnosis, and treatment.

Each year, the American Diabetes Association publishes updated clinical practice recommendations in its Standards of Care in Diabetes. These guidelines provide evidence-based recommendations for preventing and treating diabetes and its complications. The 2025 edition introduces several important updates that reflect the latest research and clinical advances.

Key Updates in the 2025 Standards

1. Continuous Glucose Monitoring for Type 2 Diabetes

The guidelines now recommend continuous glucose monitors (CGMs) for adults with type 2 diabetes using multiple daily insulin injections or insulin pumps.

Key Benefits:

•Real-time glucose data for better treatment decisions
•Reduced risk of hypoglycemia
•Improved A1C levels

2. Medication Shortage Protocols

New guidance addresses how to manage diabetes care during medication shortages, providing alternative treatment strategies to ensure continuity of care.

Clinical Recommendation: Healthcare providers should maintain a list of alternative medications and develop contingency plans to minimize treatment disruptions when preferred medications become unavailable.

3. Expanded Use of GLP-1 Receptor Agonists

The guidelines expand recommendations for GLP-1 receptor agonists, recognizing their cardiovascular and renal benefits beyond glucose control.

Patient Populations Benefiting:

✓Adults with type 2 diabetes and cardiovascular disease
✓Patients with chronic kidney disease
✓Individuals requiring weight management

4. Weight Management Pharmacotherapy Continuation

Updated recommendations emphasize the importance of continuing weight management medications long-term for sustained benefits, rather than treating them as short-term interventions.

Evidence Base: Clinical studies demonstrate that discontinuing these medications often leads to weight regain and loss of metabolic benefits.

5. MASLD Treatment with Thyroid Hormone Receptor-Beta Agonists

New recommendations include thyroid hormone receptor-beta agonists for treating metabolic dysfunction-associated steatotic liver disease (MASLD) in patients with diabetes.

This treatment option addresses an important complication that affects many individuals with type 2 diabetes and obesity.

6. Type 1 Diabetes Antibody Screening

Guidelines now recommend antibody screening for first-degree relatives of people with type 1 diabetes to enable early detection and intervention.

Benefits of Early Detection:

→Opportunity for disease-modifying therapies
→Reduced risk of diabetic ketoacidosis at diagnosis
→Better metabolic control from diagnosis

7. Cannabis Use and DKA Risk Considerations

New guidance addresses the relationship between cannabis use and increased risk of diabetic ketoacidosis (DKA), particularly in people with type 1 diabetes.

Clinical Guidance: Healthcare providers should discuss cannabis use with patients and educate them about potential risks, including increased DKA risk and effects on self-management behaviors.

8. Pregnancy Medication Safety

Updated recommendations provide clearer guidance on diabetes medication use during pregnancy and lactation, with emphasis on safety profiles of newer medications.

Key Recommendations:

•Insulin remains the preferred treatment for gestational diabetes
•Metformin may be considered in certain situations
•Preconception counseling is essential for all women of childbearing age

9. Nutrition Guidance with Plant-Based Proteins

Enhanced nutrition recommendations emphasize the benefits of plant-based protein sources as part of a balanced diabetes meal plan.

Plant-Based Protein Sources:

✓Legumes (beans, lentils, peas)

✓Nuts and seeds

✓Whole grains

✓Soy products

Accessing the Full Guidelines

The complete Standards of Care in Diabetes-2025 is published in Diabetes Care and available through the American Diabetes Association. These comprehensive guidelines cover all aspects of diabetes management, including:

•Prevention and screening recommendations
•Diagnostic criteria and classification
•Comprehensive medical evaluation
•Glycemic targets and monitoring
•Pharmacological and non-pharmacological interventions
•Management of complications
•Special populations and situations

Conclusion

The 2025 Standards of Care in Diabetes represents the most current, evidence-based guidance for diabetes management. These updates reflect significant advances in diabetes care, from new technologies like continuous glucose monitors to expanded treatment options and improved understanding of complications.

Healthcare providers and patients are encouraged to review these guidelines and discuss how the recommendations apply to individual care plans. Staying current with these evidence-based standards ensures the highest quality diabetes care and the best possible outcomes.

Disclaimer: This article provides a summary of selected updates from the 2025 Standards of Care in Diabetes. It is not intended to replace the full guidelines or professional medical advice. Always consult with your healthcare provider about your individual diabetes management plan.

American Diabetes Association Releases Standards of Care in Diabetes-2025